Kajian klinikal Limfedema di New York
5 kajian untuk Limfedema sedang mencari peserta di lokasi di New York.
Bandar di New York
Teks kajian rasmi (Bahasa Inggeris)
A Study Comparing Quality of Life in Patients With Lymphedema Who Undergo Surgical Treatment Versus Non-Surgical Management
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center, New York
- Memorial Sloan Kettering Nassau (Limited Protocol Activites), Rockville Centre
Mengambil pesertaKajian pemerhatian
Umur 18 hingga 80 · Semua jantina · Dikemas kini 24 Sep 2026 · NCT03248310A Post-market, Real-world Experience: Expanding Access to Care by Incorporating the Symani® Surgical System and Enabling Surgeons
- Erie County Medical Center, Buffalo
- Icahn School of Medicine at Mount Sinai, New York
Mengambil pesertaKajian pemerhatian
Umur 22 ke atas · Semua jantina · Dikemas kini 11 Sep 2026 · NCT06725030Lymphedema Surveillance Study
- Memorial Sloan Kettering Commack (Consent only), Commack
- Memorial Sloan Kettering Westchester (Consent only), Harrison
- Memorial Sloan Kettering Cancer Center, New York
- dan 1 lagi
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Wanita · Dikemas kini 7 Mei 2026 · NCT02743858Clinical Study to Evaluate the Effectiveness and Health Economics of a Novel Portable Non-Pneumatic Active Compression Device (NPCD) for Lymphedema/Phlebolymphedema
- Glenn Jacobowitz, New York
Mengambil peserta
Umur 18 hingga 100 · Semua jantina · Dikemas kini 4 Mei 2026 · NCT06418282A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With Breast Cancer
- Memorial Sloan Kettering Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- dan 1 lagi
Mengambil pesertaFasa 3
Umur 18 hingga 75 · Wanita · Dikemas kini 10 Nov 2025 · NCT06144164Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.